FFIV Financial Statements & Analysis
Complete financial statements for FFIV including income statement, balance sheet, and cash flow statement. Analyze FFIV's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
66
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
0.1% ↑
Net Income
43.5% ↑
Gross Margin
1.6% ↑
Operating Margin
39.2% ↑
Balance Sheet
Current Ratio
12.8% ↑
Debt to Equity
-20.5% ↑
Asset Turnover
-6.4% ↓
Cash Flow
Operating Cash Flow
21.3% ↑
Net Cash Flow
618.4% ↑
Free Cash Flow
27.2% ↑
Cash Flow to Debt
36.5% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 2.81B | 2.82B | 0.1% | |
| Gross Profit | 2.22B | 2.26B | 1.7% | |
| Operating Income | 472.57M | 658.59M | 39.4% | |
| Net Income | 394.95M | 566.78M | 43.5% | |
| EPS | 6.59 | 9.65 | 46.4% | |
| EBITDA | 650.66M | 774.24M | 19.0% | |
| Gross Margin | 78.91% | 80.20% | 1.6% | |
| Operating Margin | 16.80% | 23.39% | 39.2% | |
| Net Income Margin | 14.04% | 20.13% | 43.4% | |
| R&D Expenses | 540.28M | 490.12M | 9.3% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 2.82B | 2.81B | 2.70B | 2.60B | 2.35B |
| Gross Profit | 2.26B | 2.22B | 2.16B | 2.11B | 1.94B |
| Operating Income | 658.59M | 472.57M | 403.79M | 394.02M | 392.27M |
| Net Income | 566.78M | 394.95M | 322.16M | 331.24M | 307.44M |
| EPS | 9.65 | 6.59 | 5.34 | 5.46 | 5.05 |
| EBITDA | 774.24M | 650.66M | 533.49M | 509.45M | 564.00M |
| Gross Margin | 80.20% | 78.91% | 79.98% | 81.06% | 82.65% |
| Operating Margin | 23.39% | 16.80% | 14.98% | 15.13% | 16.69% |
| Net Income Margin | 20.13% | 14.04% | 11.95% | 12.72% | 13.08% |
| R&D Expenses | 490.12M | 540.28M | 543.37M | 512.63M | 441.32M |